Wuhan will bargain for 30 key monitoring drugs And the price of enterprise quotations will drop by at least 30%.

On August 3rd, Wuhan Pharmaceutical Joint Purchasing Office issued the Regulations on the Implementation of Key Monitoring of Reasonable Drug Bargaining in Wuhan City in 2020 and the List of Key Monitoring of Reasonable Drug Bargaining Drugs.
According to the catalog, bargaining drugs are mainly based on the first batch of national key supervision of rational drug catalogue issued by the National Health Care Commission last year, the first batch of key monitoring reasonable drug catalogue in Hubei Province and the list of key monitoring drugs designated by medical institutions in Wuhan City.
From the enterprise declaration conditions, enterprises are required to hang up the network in the provincial equipment collection platform and in the last three years in the provincial platform and provincial medical institutions have transaction records, and within three years no major quality and safety accidents or serious violations of laws and regulations.
quote requires enterprises not to be higher than the June 30 national provincial minimum price (excluding Anhui, Fujian, Guangdong, Chongqing), the maximum price (valid quotation) for enterprise varieties of provincial net minimum price of 0.7 times, higher than the maximum price of the offer is invalid.
specific documents for the bargaining process are as follows: